Annual Report

Overview

The report highlights approval of the Phase I clinical trial for ES2B-C001, progress on the HER2 breast-cancer vaccine, and a signed malaria term sheet with the Serum Institute of India. It also reports an 18-person full-time workforce at year-end, with 60% women and a 50:50 board gender ratio. Sustainability coverage addresses ethical research, employee health and safety, anti-bribery, environmental responsibility, and data ethics.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 1 May 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services